Wednesday, April 30, 2014

NevBio to Join the SciTech Showcase & Dinner on October 24, 2013

Last Day to Buy Tickets:  SciTech Showcase & Dinner on Oct 24, 2013 in Las Vegas at the World Market Center


Nancy Phillips, CEO of ViaWest
One of the Largest Privately Owned Data-Center Companies in the Nation  
Darik Volpa, CEO of
Named "Most Inspiring" by PharmaVOICE
Thursday, October 24, 2013
4 pm Showcase & Cocktails
6 pm Dinner & Program
World Market Center
RSVP here
Last day to buy tickets (Oct 15th)

Don't Miss the Exhibitors: 
NevBio, Actus Biotechnologies, BridgeBank, 
BNY Mellon, Brennan Capital Partners, 
Bruce & Banka CPAs, The City of Henderson, 
City National Bank, Cleveland Clinic, CorCell, 
Equon Pharmaceuticals, Inc., Hamilton Lane, 
Howard & Howard, Las Vegas Business Press, 
Las Vegas Internet Hospital, 
Lucine Biotechnology,Inc., Maverick Angels, 
Nevada State College, Phoenix Staff, Quantion Advisors, Quertle, SableSystems, Skinvisible Pharmaceuticals, Ubiquita,,
Varian Medical Systems & ViaWest. 

Join researchers, friends, co-workers & supporters of science and technology in Southern Nevada.

NevBio Recognizes Cancer Researchers In Southern Nevada

Nevada Biotechnology & Health Science Consortium
and Lionel Sawyer & Collins 
are pleased to host a Cocktail Party 
Cancer Researchers in Southern Nevada
Saturday, September 28, 2013
6 pm to 10 pm
At the Loft of Mohamed Iqbal, Esq. 
Soho Lofts Unit 807, 900 Las Vegas Boulevard South, Las Vegas, Nevada 89101
No Cost to attend, please RSVP
*Limited Room*

Come join fellow researchers, friends, co-workers & supporters. Please forward this email to others that might want to attend. 

The Nevada Biotechnology & Health Science Consortium wants to recognize those who continue to research treatments for cancer in Southern Nevada and those who have supported, continue to support and/or are interested in cancer research in Southern Nevada. PleaseRSVP.

We are asking researchers to provide an update on their current work in Southern Nevada by giving a brief 5 minute talk at the event (limited spots).

We want to thank our host, Mohamed Iqbal, a litigator with Lionel Sawyer & Collins, whose practice includes international pharmacovigilance and negotiating clinical research agreements. He also addresses IP protection issues, advises start-ups, and has appeared before an FDA Advisory Board in Washington, D.C.

Growing a Life Science industry in Las Vegas is achievable.

Ross Newman will speak at the September 11, 2013 NevBio luncheon. He believes that if a biotech industry is going to be created in Las Vegas it will need: 

1) Commitment - by talented and hardworking people that will ultimately benefit from a biotech industry:
*Experienced Management personnel in pharma/biotech
*Regulatory & Clinical study management
2) Risk Capital & equity man hours 
3) Faith (not hope)

Join us for this discussion on the future of biotechnology in Las Vegas.

Ross Newman, CEO of Innovative Health Research to Speak on the Creation of a Biotech Cluster in Southern Nevada

Ross W. Newman will speak at the NevBio meeting on September 11, 2013. He began his  30+ year career in pharmaceutical/biotech research working as a West Coast correspondent of the investment banking firm Allen & Co. In that role, he directed capital into-and sat on the board of directors of-many early biotech start-ups developed from research coming out of the University of California, San Francisco and Stanford University. As one of the start-ups was failing, he was selected by the board to become the company's new CEO. Newman was just in his 20's when he directed the shut-down and merger into Xoma, Inc. of one of the first monoclonal antibody companies in the country to go into clinical trials and fail. Early in his career, he lost a couple million dollars of his own money (most of which was borrowed, he says) and close to $20 million of investor money. It took until 1996 to pay off his debt. Newman earned a BA in Political Demography from the University of California, Berkeley in 1971. After graduating, he traveled. In 1973, he returned to Berkeley where he completed his doctoral dissertation in epistemology in 1977.